The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20080124
The Journal of Experimental Medicine, Vol. 205, No. 6, 1269-1276
The Rockefeller University Press, 0022-1007 $30.00
© Fong et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3041K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fong, C. H. Y.
Right arrow Articles by Lawrence, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, C. H. Y.
Right arrow Articles by Lawrence, T.
Related Collections
Right arrowRelated Articles
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

 An antiinflammatory role for IKKβ through the inhibition of "classical" macrophage activation

Carol Ho Yan Fong1,2, Magali Bebien1,2, Arnaud Didierlaurent1, Ruth Nebauer1,2, Tracy Hussell1, David Broide3, Michael Karin4, and Toby Lawrence1,2

1 Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, W6 8LH, UK
2 Centre for Cancer and Inflammation, Institute of Cancer and CR-UK Clinical Centre, Bart's and The London School of Medicine and Dentistry, London EC1M 6BQ, UK
3 Department of Medicine and 4 Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92103

CORRESPONDENCE Toby Lawrence: t.lawrence{at}qmul.ac.uk

The nuclear factor {kappa}B (NF-{kappa}B) pathway plays a central role in inflammation and immunity. In response to proinflammatory cytokines and pathogen-associated molecular patterns, NF-{kappa}B activation is controlled by I{kappa}B kinase (IKK)β. Using Cre/lox-mediated gene targeting of IKKβ, we have uncovered a tissue-specific role for IKKβ during infection with group B streptococcus. Although deletion of IKKβ in airway epithelial cells had the predicted effect of inhibiting inflammation and reducing innate immunity, deletion of IKKβ in the myeloid lineage unexpectedly conferred resistance to infection that was associated with increased expression of interleukin (IL)-12, inducible nitric oxide synthase (NOS2), and major histocompatibility complex (MHC) class II by macrophages. We also describe a previously unknown role for IKKβ in the inhibition of signal transducer and activator of transcription (Stat)1 signaling in macrophages, which is critical for IL-12, NOS2, and MHC class II expression. These studies suggest that IKKβ inhibits the "classically" activated or M1 macrophage phenotype during infection through negative cross talk with the Stat1 pathway. This may represent a mechanism to prevent the over-exuberant activation of macrophages during infection and contribute to the resolution of inflammation. This establishes a new role for IKKβ in the regulation of macrophage activation with important implications in chronic inflammatory disease, infection, and cancer.

C.H.Y. Fong and M. Bebien contributed equally to this work.

© 2008 Fong et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Articles

"Re-educating" tumor-associated macrophages by targeting NF-{kappa}B
Thorsten Hagemann, Toby Lawrence, Iain McNeish, Kellie A. Charles, Hagen Kulbe, Richard G. Thompson, Stephen C. Robinson, and Frances R. Balkwill
J. Exp. Med. 2008 205: 1261-1268. [Abstract] [Full Text] [PDF]

IKKβ/NF-{kappa}B and the miscreant macrophage
Anjuli M. Timmer and Victor Nizet
J. Exp. Med. 2008 205: 1255-1259. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS